#NewAseBioMember | “This partnership gives us the possibility to establish key contacts an... 20/05/2024 Healthcare Access to innovation Innovative drugs Personalized medicine Advanced therapies Meet Kirsch Pharma, our new member. We talked to its Raquel Márquez Duro, Key Account Mánager de España y Portugal. AseBio - Kirsch Pharma España
#AseBioID24 | “Being present at Investor Day gives you wings to visualize, work and promot... 08/05/2024 Healthcare Access to innovation Advanced therapies Financing Hector Olabegogeaskoetxea Narbaiza, CEO of MONDRAGON Health, Silver Sponsor of AseBio Investor Day, analyzes the biotech... AseBio
Oryzon reports financial results and corporate update for quarter ended March 31, 2024 07/05/2024 Healthcare Access to innovation Rare diseases Personalized medicine Advanced therapies Financing Finalizing full data analysis from vafidemstat's PORTICO Phase IIb trial in Borderline Personality Disorder (BPD)... Partners - Oryzon Genomics
Creation of new 3D liver cell models for research 30/04/2024 Healthcare Access to innovation Innovative drugs Personalized medicine Advanced therapies The main objective of the project is the creation of innovative in vitro models using microencapsulation of human liver... Partners - BeCytes Biotechnologies
The synergy between biotechnology and immunology catalyzes the development of more effecti... 29/04/2024 Healthcare Drug discovery Innovative drugs Personalized medicine Advanced therapies Biotechnology has achieved significant advances in diagnosis and precision therapies, the production of biotechnological... AseBio
The synergy between biotechnology and immunology catalyzes the development of more effecti... 29/04/2024 Biotechnology has achieved significant advances in diagnosis and precision therapies, the production of biotechnological... AseBio
Biotechnology and DNA: The duo paving the way for the era of customization in health and a... 25/04/2024 Next-generation DNA sequencing has a significant impact on personalized medicine, genomic research, and the... AseBio
Vaxdyn and the University of Latvia have obtained funding from the EUROSTARS program to pr... 22/04/2024 Healthcare Access to innovation Advanced therapies They receive a grant of half a million euros to prepare the clinical and commercial strategy for vaccination against... Partners - Vaxdyn
ORYZON secures another important patent for its lead CNS asset, vafidemstat 22/04/2024 Healthcare Drug discovery Innovative drugs Advanced therapies Has received “Intention to Grant” from the European Patent Office. Partners - Oryzon Genomics
The "yes" from the European Parliament to the reform of pharmaceutical legislation jeopard... 12/04/2024 Healthcare Access to innovation Drug discovery Innovative drugs Personalized medicine Advanced therapies Antibiotic resistance Biotechnology has radically transformed the discovery of new drugs: 68% of the drugs currently in development globally... AseBio
